Öz, Gülin

N-acetylcysteine Boosts Brain and Blood Glutathione in Gaucher and Parkinson Diseases

Holmay, M. J., Terpstra, M., Coles, L. D., Mishra, U., Ahlskog, M., Öz, G., Cloyd, J. C., & Tuite, P. J. (2013) · Clinical Neuropharmacology

Parkinson's Disease Mechanisms and TreatmentsSulfur Compounds in Biology

Cited by 216

Repeated‐Dose Oral N‐Acetylcysteine in Parkinson's Disease: Pharmacokinetics and Effect on Brain Glutathione and Oxidative Stress

Coles, L. D., Tuite, P. J., Öz, G., Mishra, U. R., Kartha, R. V., Sullivan, K. M., Cloyd, J. C., & Terpstra, M. (2018) · The Journal of Clinical Pharmacology

Parkinson's Disease Mechanisms and TreatmentsSulfur Compounds in Biology

Cited by 170

Antisense oligonucleotide–mediated ataxin-1 reduction prolongs survival in SCA1 mice and reveals disease-associated transcriptome profiles

Friedrich, J., Kordasiewicz, H. B., O’Callaghan, B., Handler, H. P., Wagener, C., Duvick, L., Swayze, E. E., Rainwater, O., Hofstra, B., Benneyworth, M., et al. (2018) · JCI Insight

Genetic Neurodegenerative DiseasesAmyotrophic Lateral Sclerosis Research

Cited by 121

Hypothalamic glucose transport in humans during experimentally induced hypoglycemia-associated autonomic failure

Seaquist, E. R., Moheet, A., Kumar, A., Deelchand, D. K., Terpstra, M., Kubisiak, K., Eberly, L. E., Henry, P.-G., Joers, J. M., & Öz, G. (2017) · The Journal of Clinical Endocrinology & Metabolism

Diabetes Management and ResearchNeurological and metabolic disorders

Cited by 19